Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lasofoxifene × Clear all

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 621 Carboplatin 513 Paclitaxel 499 Cyclophosphamide 457 Radiotherapy 455 Docetaxel 415 Fluorouracil 391 Gemcitabine 368 Doxorubicin 346 Capecitabine 322 Dexamethasone 285 Oxaliplatin 251 Leucovorin 241 Vincristine 238 pembrolizumab 237 Etoposide 234 Bevacizumab 229 Rituximab 210 Prednisone 202 Pemetrexed 183 Cytarabine 181 Drug Therapy 173 Methotrexate 153 Trastuzumab 149 Irinotecan 143 Lenalidomide 123 Filgrastim 120 Nivolumab 113 Chemotherapy, Adjuvant 111 Tamoxifen 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05696626 2026-01-26

ELAINEIII

Sermonix Pharmaceuticals Inc.

Phase 3 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡